Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Early Earnings Season: Medical Devices Flat; Biopharmas Higher

publication date: Nov 13, 2009

Earnings season has now arrived, and China life science companies are reporting financial results from their most recent quarters. Although Mindray Medical, the medical device maker, announced a flat quarter, four small biopharmas had the pleasure of telling investors that revenues and profits are back on a significant upswing. All China life science companies may not follow this pattern, but it is a refreshing change to read earnings reports that do not have to mention the unsettled conditions caused by a worldwide financial crisis. More details...

Stock Symbols: (NYSE: MR)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital